Andreja Emeršič

1.1k total citations
24 papers, 627 citations indexed

About

Andreja Emeršič is a scholar working on Physiology, Psychiatry and Mental health and Neurology. According to data from OpenAlex, Andreja Emeršič has authored 24 papers receiving a total of 627 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Physiology, 12 papers in Psychiatry and Mental health and 7 papers in Neurology. Recurrent topics in Andreja Emeršič's work include Alzheimer's disease research and treatments (14 papers), Dementia and Cognitive Impairment Research (10 papers) and Multiple Sclerosis Research Studies (5 papers). Andreja Emeršič is often cited by papers focused on Alzheimer's disease research and treatments (14 papers), Dementia and Cognitive Impairment Research (10 papers) and Multiple Sclerosis Research Studies (5 papers). Andreja Emeršič collaborates with scholars based in Slovenia, Sweden and United Kingdom. Andreja Emeršič's co-authors include Kaj Blennow, Henrik Zetterberg, Thomas K. Karikari, Juan Lantero‐Rodriguez, Nicholas J. Ashton, Dag Aarsland, Marc Suárez‐Calvet, Andrew King, Abdul Hye and Claire Troakes and has published in prestigious journals such as Brain, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Andreja Emeršič

22 papers receiving 623 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreja Emeršič Slovenia 10 415 319 157 144 113 24 627
Amber Nolan United States 14 251 0.6× 167 0.5× 236 1.5× 166 1.2× 123 1.1× 31 727
Mari Blomberg Sweden 10 417 1.0× 316 1.0× 93 0.6× 186 1.3× 118 1.0× 12 648
G. Manetti Italy 5 401 1.0× 249 0.8× 83 0.5× 159 1.1× 82 0.7× 11 610
Leonardo Biscetti Italy 15 253 0.6× 190 0.6× 249 1.6× 156 1.1× 155 1.4× 31 669
Andréa L. Benedet United Kingdom 11 453 1.1× 353 1.1× 76 0.5× 148 1.0× 120 1.1× 16 645
E Van Kerschaver Belgium 4 552 1.3× 336 1.1× 93 0.6× 212 1.5× 123 1.1× 5 682
Miharu Samuraki Japan 13 231 0.6× 195 0.6× 121 0.8× 110 0.8× 107 0.9× 28 620
Nicholas J. Ashton United Kingdom 13 336 0.8× 248 0.8× 69 0.4× 136 0.9× 89 0.8× 55 539
Ekaterina Manuilova Russia 13 447 1.1× 408 1.3× 73 0.5× 249 1.7× 94 0.8× 47 864
Miguel A. Riudavets United States 12 293 0.7× 116 0.4× 54 0.3× 132 0.9× 136 1.2× 16 522

Countries citing papers authored by Andreja Emeršič

Since Specialization
Citations

This map shows the geographic impact of Andreja Emeršič's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreja Emeršič with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreja Emeršič more than expected).

Fields of papers citing papers by Andreja Emeršič

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreja Emeršič. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreja Emeršič. The network helps show where Andreja Emeršič may publish in the future.

Co-authorship network of co-authors of Andreja Emeršič

This figure shows the co-authorship network connecting the top 25 collaborators of Andreja Emeršič. A scholar is included among the top collaborators of Andreja Emeršič based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreja Emeršič. Andreja Emeršič is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kramberger, Milica G., Vita Dolžan, Andreja Emeršič, et al.. (2025). The role of age and sex in paraoxonase 1 activity in patients with Alzheimer's dementia. Chemico-Biological Interactions. 422. 111787–111787.
2.
Wimo, Anders, Ron Handels, Kaj Blennow, et al.. (2025). Cost-effectiveness of diagnosing and treating patients with early Alzheimer's disease with anti-amyloid treatment in a clinical setting. Journal of Alzheimer s Disease. 104(4). 1167–1184. 4 indexed citations
3.
Blagus, Tanja, Maja Trošt, Milica G. Kramberger, et al.. (2024). Genetic variability of incretin receptors affects the occurrence of neurodegenerative diseases and their characteristics. Heliyon. 10(20). e39157–e39157. 1 indexed citations
4.
Emeršič, Andreja, Thomas K. Karikari, Przemysław R. Kac, et al.. (2024). Biomarkers of tau phosphorylation state are associated with the clinical course of multiple sclerosis. Multiple Sclerosis and Related Disorders. 90. 105801–105801. 2 indexed citations
5.
Emeršič, Andreja, Nicholas J. Ashton, Agathe Vrillon, et al.. (2024). Cerebrospinal fluid p‐tau181, 217, and 231 in definite Creutzfeldt–Jakob disease with and without concomitant pathologies. Alzheimer s & Dementia. 20(8). 5324–5337. 3 indexed citations
6.
Wimo, Anders, Bjørn‐Eivind Kirsebom, Andreja Emeršič, et al.. (2024). Costs of diagnosing early Alzheimer's disease in three European memory clinic settings: Results from the precision medicine in Alzheimer's disease project. International Journal of Geriatric Psychiatry. 39(7). e6126–e6126. 3 indexed citations
7.
Emeršič, Andreja, et al.. (2024). Slovenian Memory Clinic Organization with the Introduction of Potential New Alzheimer’s Disease Treatment. Journal of Alzheimer s Disease. 99(2). 471–476.
8.
Kramberger, Milica G., et al.. (2023). Genetic Polymorphisms in Oxidative Stress and Inflammatory Pathways as Potential Biomarkers in Alzheimer’s Disease and Dementia. Antioxidants. 12(2). 316–316. 19 indexed citations
9.
Kramberger, Milica G., et al.. (2023). The Association of Selected GWAS Reported AD Risk Loci with CSF Biomarker Levels and Cognitive Decline in Slovenian Patients. International Journal of Molecular Sciences. 24(16). 12966–12966. 1 indexed citations
10.
Hegen, Harald, Klaus Berek, Paola Cavalla, et al.. (2023). Diagnostic value of kappa free light chain index in patients with primary progressive multiple sclerosis – a multicentre study. Frontiers in Immunology. 14. 1327947–1327947. 10 indexed citations
11.
Emeršič, Andreja, et al.. (2022). Identification and validation of Alzheimer’s disease-related metabolic brain pattern in biomarker confirmed Alzheimer’s dementia patients. Scientific Reports. 12(1). 11752–11752. 16 indexed citations
12.
Habek, Mario, Vanja Bašić Kes, Dunja Rogić, et al.. (2021). Humoral immune response in convalescent COVID-19 people with multiple sclerosis treated with high-efficacy disease-modifying therapies: A multicenter, case-control study. Journal of Neuroimmunology. 359. 577696–577696. 12 indexed citations
13.
Ležaić, Luka, Andreja Emeršič, Milica G. Kramberger, et al.. (2021). Abnormal metabolic brain network in behavioral variant of frontotemporal dementia. Alzheimer s & Dementia. 17(S4). 1 indexed citations
14.
Karikari, Thomas K., Andreja Emeršič, Agathe Vrillon, et al.. (2020). Head‐to‐head comparison of clinical performance of CSF phospho‐tau T181 and T217 biomarkers for Alzheimer's disease diagnosis. Alzheimer s & Dementia. 17(5). 755–767. 95 indexed citations
15.
Benussi, Alberto, Thomas K. Karikari, Nicholas J. Ashton, et al.. (2020). Diagnostic and prognostic value of serum NfL and p-Tau181in frontotemporal lobar degeneration. Journal of Neurology Neurosurgery & Psychiatry. 91(9). 960–967. 102 indexed citations
16.
Lantero‐Rodriguez, Juan, Thomas K. Karikari, Marc Suárez‐Calvet, et al.. (2020). Plasma p-tau181 accurately predicts Alzheimer’s disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline. Acta Neuropathologica. 140(3). 267–278. 222 indexed citations
17.
18.
Rot, Uroš, Åsa Sandelius, Andreja Emeršič, Henrik Zetterberg, & Kaj Blennow. (2018). Cerebrospinal fluid GAP-43 in early multiple sclerosis. Multiple Sclerosis Journal - Experimental Translational and Clinical. 4(3). 2453212899–2453212899. 5 indexed citations
19.
Emeršič, Andreja, et al.. (2018). Intrathecal immunoglobulin synthesis: The potential value of an adjunct test. Clinica Chimica Acta. 489. 109–116. 22 indexed citations
20.
Kramberger, Milica G., Andreja Emeršič, Uroš Rot, et al.. (2014). P2‐093: THE ROLE OF NEUROPSYCHOLOGICAL ASSESSMENT IN PREDICTING CSF DEMENTIA MEASURES IN MILD COGNITIVE IMPAIRMENT. Alzheimer s & Dementia. 10(4S_Part_13). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amber Nolan Breakdown of academic impact, for papers by Mari Blomberg Breakdown of academic impact, for papers by G. Manetti Breakdown of academic impact, for papers by Leonardo Biscetti Breakdown of academic impact, for papers by Andréa L. Benedet Breakdown of academic impact, for papers by E Van Kerschaver Breakdown of academic impact, for papers by Miharu Samuraki Breakdown of academic impact, for papers by Nicholas J. Ashton Breakdown of academic impact, for papers by Ekaterina Manuilova Breakdown of academic impact, for papers by Miguel A. Riudavets
Rankless by CCL
2026